Yahoo Web Search

Sign In

Search results

  1. www.jaad.org › article › S0190-9622(24)02550-7Efficacy and safety of deuruxolitinib, an oral selective Janus...

    3 days ago · Dr King has served on advisory boards and/or is a consultant and/or is a clinical trial investigator for AbbVie, AltruBio Inc., Almirall, AnaptysBio, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Myers Squibb, CoNCERT Pharmaceuticals (subsequently acquired by Sun Pharmaceutical Industries Limited), Equillium, Horizon Therapeutics, Eli ...

  2. Videos

    View all

  3. www.marketbeat.com › stocks › NASDAQHorizon Therapeutics Public (HZNP) Stock Price, News & Analysis

    1 day ago · Should You Buy or Sell Horizon Therapeutics Public Stock? Get The Latest HZNP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

    • 1 BURLINGTON ROAD CONNAUGHT HOUSE 1ST FLOOR, Dublin L2, D04 C5Y6
    • investor-relations@horizontherapeutics.com
    • (531) 772-2100
    • 2.1K

  4. www.liebertpub.com › doi › 10Levels of Exon-Skipping Are Not Artificially Overestimated...

    2 days ago · Antisense oligonucleotides (ASO) are very promising drugs for numerous diseases including neuromuscular disorders such as Duchenne muscular dystrophy (DMD). Several ASO drugs have already been approved by the US Food and Drug Administration for DMD and global efforts are still ongoing to improve further their potency, notably by developing new delivery systems or alternative chemistries. In ...

  5. www.biospace.com › article › biospace-layoff-tracker-2023Biopharma Layoff Tracker 2024: Merck, Rapt, Aslan and More Cut...

    2 days ago · Amgen is letting go of 350 employees following its $27.8 billion acquisition of Horizon Therapeutics, according to several media reports on Tuesday. The layoffs will affect Horizon roles that overlap with existing teams at Amgen, a company spokesperson told Fierce Pharma.

  6. www.medrxiv.org › content › 10Brain-first forms of Parkinson′s Disease are over-represented in...

    2 days ago · Motor subtypes in Parkinson′s Disease (PD) are unstable over time, limiting mechanistic insights and biomarker discovery. We focused on Rest Tremor (RT) as a symptom to test for phenotype stability and link them to specific circuits and disease mechanisms. Using the PPMI cohort data over 5 years we found that RT we found that RT is more stable than common Tremor- Dominant definitions, a ...

  7. finance.yahoo.com › news › tersera-therapeutics-llc-announcesTersera Therapeutics LLC Announces That the 2024 Polyanalgesic...

    3 days ago · TerSera Therapeutics is a biopharmaceutical company with a focus in oncology, acute care, and non-opioid pain management. ... These 2 Healthcare Stocks Have Big Catalysts on the Horizon.

  8. biopharmajournal.com › 2024/07/24 › viking-therapeutics-stockViking Therapeutics stock (VKTX) could hit all time high and...

    2 days ago · Viking Therapeutics is poised for a transformative year with multiple key milestones on the horizon. From advancing VK2735 for obesity to progressing VK2809 in NASH/MASH and exploring novel treatments for X-ALD and obesity, the company’s robust pipeline reflects its commitment to addressing significant unmet medical needs.